scholarly journals Scoping review of clinical practice guidelines on the management of benign liver tumours

2021 ◽  
Vol 8 (1) ◽  
pp. e000592
Author(s):  
Martijn P D Haring ◽  
Frans J C Cuperus ◽  
Evelien W Duiker ◽  
Robbert J de Haas ◽  
Vincent E de Meijer
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Scoping Review ◽  
English Language ◽  
Management Strategies ◽  
Hepatocellular Adenoma ◽  
Liver Tumours ◽  
Scoping Reviews ◽  
Benign Liver

ObjectiveBenign liver tumours (BLT) are increasingly diagnosed as incidentalomas. Clinical implications and management vary across and within the different types of BLT. High-quality clinical practice guidelines are needed, because of the many nuances in tumour types, diagnostic modalities, and conservative and invasive management strategies. Yet, available observational evidence is subject to interpretation which may lead to practice variation. Therefore, we aimed to systematically search for available clinical practice guidelines on BLT, to critically appraise them, and to compare management recommendations.DesignA scoping review was performed within MEDLINE, EMBASE, and Web of Science. All BLT guidelines published in peer-reviewed, and English language journals were eligible for inclusion. Clinical practice guidelines on BLT were analysed, compared, and critically appraised using the Appraisal of Guidelines, Research and Evaluation (AGREE II) checklist regarding hepatic haemangioma, focal nodular hyperplasia (FNH), and hepatocellular adenoma (HCA). Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations (PRISMA) for scoping reviews were adhered to.ResultsThe literature search yielded unique 367 papers, 348 were excluded after screening of title/abstract, and 16 after full-text screening. Three guidelines were included: the American College of Gastroenterology (ACG; 2014), Brazilian Society of Hepatology (SBH; 2015), and European Association for the Study of the Liver (EASL; 2016). There was no uniformity in the assessment methods for grading and gravity of recommendations between guidelines. Among observed differences were: (1) indications for biopsy in all three tumours; (2) advices on contraceptive pills and follow-up in FNH and HCA; (3) use of an individualised approach to HCA; (4) absence of recommendations for treatment of HCA in men; and (5) approaches to HCA subtype identification on magnetic resonance imaging.ConclusionRecognising differences in recommendations can assist in harmonisation of practice standards and identify unmet needs in research. This may ultimately contribute to improved global patient care.

Clinical practice guidelines for acute and post-acute care of patients with spinal cord injury: a scoping review protocol

2021 ◽  
Vol 17 (3) ◽  
pp. 105-112
Author(s):  
Marianne Pearl Gregorio ◽  
Kiran Pohar Manhas ◽  
Katelyn Brehon ◽  
Marcus Vaska ◽  
Glenda Moore ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Scoping Review ◽  
Scoping Reviews ◽  
Cord Injury ◽  
Review Protocol

Background: Spinal cord injury (SCI) impacts quality of life. Clinical practice guidelines (CPG) for comprehensive SCI care are not completely agreed upon, leading to considerable variability in care and patient outcomes. Aims: We aim to summarise and critically evaluate existing CPGs for the care of patients with SCI at the acute and post-acute phase of their care, and to identify gaps in guidance for nursing and multidisciplinary care. Methods: The scoping review protocol was directed by the Joanna Briggs Institute (JBI) guidelines and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) reporting guideline. Some 13 databases will be searched for eligible CPGs. Two independent reviewers will screen and extract data using pre-specified eligibility criteria. The quality of CPGs will be appraised using the AGREE II tool.

scholarly journals Patient and public involvement in the development of clinical practice guidelines: a scoping review protocol

BMJ Open ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. e037327
Author(s):  
Elizabeth Ann Bryant ◽  
Anna Mae Scott ◽  
Rae Thomas
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Scoping Review ◽  
Public Involvement ◽  
Patient And Public Involvement ◽  
National Standards ◽  
Future Research ◽  
Scoping Reviews ◽  
The Usa

IntroductionClinical practice guidelines (CPGs) are intended to optimise patient care by recommending care pathways based on the best available research evidence and practice experience. Patient and public involvement (PPI) in healthcare is recommended based on the expectation that it will improve the quality and relevance of outcomes. There is no consensus on what constitutes meaningful and effective PPI in CPG. We will conduct a scoping review to identify and synthesise knowledge in four key areas: who have been the patients and public previously involved in CPG development, how were they recruited, at what stage in the CPG process were they involved and how were they involved. This knowledge will inform a general model of PPI in CPG to inform CPGs development.Methods and analysisWe will conduct a scoping review using the Methodology for Scoping Reviews refined by the Joanna Briggs Institute. Searches will be conducted in electronic databases (PubMed, Embase, CINAHL and PsycINFO). National standards for developing CPGs from Australia, UK, Canada and the USA will also be identified. A forward and backward citation search will be conducted on the included studies and national standards. Abstracts and full-text studies will be independently screened by two researchers. Extracted data will include study details, type of clinical guideline and the four key areas, which patients and public were involved, how were they recruited, at what stage were they included and how they were involved. Data will be narratively synthesised.Ethics and disseminationAs a scoping review, this study does not require ethics approval. We intend to disseminate the results through publication in a peer-reviewed journal and conference presentations. Furthermore, we will use the findings from our scoping review to inform future research to fill key evidence gaps identified by this review.

Scoping Review of Clinical Practice Guidelines for Fall Risk Screening and Assessment in Older Adults across the Care Continuum

2020 ◽  
pp. 1-18
Author(s):  
Hazel Williams-Roberts ◽  
Catherine Arnold ◽  
Daphne Kemp ◽  
Alexander Crizzle ◽  
Shanthi Johnson
Keyword(s):  
Older Adults ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Scoping Review ◽  
Fall Risk ◽  
Community Dwelling ◽  
Risk Screening ◽  
Care Continuum ◽  
Fall Risk Screening

ABSTRACT Given the rising numbers of older adults in Canada experiencing falls, evidence-based identification of fall risks and plans for prevention across the continuum of care is a significant priority for health care providers. A scoping review was conducted to synthesize published international clinical practice guidelines (CPGs) and recommendations for fall risk screening and assessment in older adults (defined as 65 years of age and older). Of the 22 CPGs, 6 pertained to multiple settings, 9 pertained to community-dwelling older adults only, 2 each pertained to acute care and long-term care settings only, and 3 did not specify setting. Two criteria, prior fall history and gait and balance abnormalities, were applied either independently or sequentially in 19 CPG fall risk screening algorithms. Fall risk assessment components were more varied across CPGs but commonly included: detailed fall history; detailed evaluation of gait, balance, and/or mobility; medication review; vision; and environmental hazards assessment. Despite these similarities, more work is needed to streamline assessment approaches for heterogeneous and complex older adult populations across the care continuum. Support is also needed for sustainable implementation of CPGs in order to improve health outcomes.

scholarly journals ABPI reporting and compression recommendations in global clinical practice guidelines on venous leg ulcer management: A scoping review

2018 ◽  
Vol 16 (2) ◽  
pp. 406-419 ◽  
Author(s):  
Carolina D. Weller ◽  
Victoria Team ◽  
John D. Ivory ◽  
Kimberley Crawford ◽  
Georgina Gethin
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Scoping Review ◽  
Leg Ulcer ◽  
Venous Leg Ulcer

Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions

2019 ◽  
Vol 54 (2) ◽  
pp. 171-177 ◽  
Author(s):  
Daniel R. Migliozzi ◽  
Nicole J. Asal
Keyword(s):  
Clinical Practice ◽  
Drug Interactions ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
English Language ◽  
Data Extraction ◽  
Organic Anion ◽  
Calcineurin Inhibitors ◽  
Interaction Database

Objective: To review the available literature that provides evidence for the absence of statin interactions with tacrolimus compared with cyclosporine. Data Sources: A literature search of PubMed was performed (1990 to June 2019) using the following search terms: calcineurin inhibitors, tacrolimus, cyclosporine, statins, atorvastatin, simvastatin, and drug interactions. Clinical practice guidelines, article bibliographies, drug interaction database references, and product monographs were also reviewed. Study Selection and Data Extraction: Relevant English-language studies describing the mechanism of interaction, the magnitude of pharmacokinetic alterations, and safety were evaluated. In vitro data and studies conducted in adult humans were considered. Data Synthesis: Studies demonstrate pharmacokinetic differences between cyclosporine and tacrolimus, particularly with regard to inhibition of 2 hepatic transporters: P-glycoprotein and organic anion transporting polypeptide (OATP). Compared with cyclosporine, tacrolimus does not affect these transporters, does not enhance statin exposure, and does not increase statin-associated safety events. Relevance to Patient Care and Clinical Practice: Clinical practice guidelines allude to the need to reduce statin doses in the setting of tacrolimus. Some providers have adopted this practice, and doing so may prevent transplant recipients from attaining cardiovascular benefit, especially when increased or high-intensity doses are required. The pharmacokinetic differences between tacrolimus and cyclosporine highlight different interaction potential with statins. Conclusions: Clinicians need to be aware that tacrolimus and cyclosporine are not the same with regard to causing drug interactions with statins. Tacrolimus can be used with statins without the need for dose adjustments because of lack of an interaction.

Scoping review of clinical practice guidelines for the early management of stroke with focus on endovascular treatment

2021 ◽  
Author(s):  
Alba Navarro-Flores ◽  
Christoper A. Alarcon-Ruiz ◽  
Cristian Morán-Mariños ◽  
Alvaro Taype-Rondan ◽  
Joel Sequeiros Chirinos ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Endovascular Treatment ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Scoping Review ◽  
Early Management
Sign in / Sign up

Export Citation Format

Share Document